| Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression FB Rivera, GNO Lumbang, DRM Gaid, LLA Cruz, JV Magalong, ... Diabetes, Obesity and Metabolism 26 (6), 2209-2228, 2024 | 6 | 2024 |
| Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo … FB Rivera, LLA Cruz, JV Magalong, JMMJ Ruyeras, JP Aparece, ... American Journal of Preventive Cardiology 18, 100679, 2024 | 3 | 2024 |
| Trends of nonalcoholic fatty liver research in Southeast Asia from 2004 to 2022: A bibliometric analysis VJD Josol, PBU Salvador, LLA Cruz, EDB Ornos, OAG Tantengco Obesity Medicine 45, 100527, 2024 | 1 | 2024 |
| Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression FB Rivera, SW Cha, JV Magalong, NRB Bantayan, LLA Cruz, ... Current Medical Research and Opinion, 1-42, 2024 | | 2024 |
| Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes … FB Rivera, NRB Bantayan, JP Aparece, LLA Cruz, JV Magallong, PL Pine, ... Journal of Clinical Lipidology, 2024 | | 2024 |
| Development and Validation of a Stressor-Coping Style Scale for Students in a Public Medical School AE Chiong III, EJD Corpus, SPL Coralde, NKA Coronel, JTY Chuatak, ... Acta Medica Philippina, 2024 | | 2024 |
| On the pH and Acid Neutralizing Capacity Profile of Manila Bay Coastal Water Samples in Manila, Philippines DEP Sumalapao, LLA Cruz, SKN Cua, HVG Dauigoy, EA De Leon Manila Journal of Science 9, 104-113, 2016 | | 2016 |
Frederick Berro Rivera, MDLincoln Medical Center在 nychhc.org 的电子邮件经过验证
